WiSys Technologies

Precision Delay Monitoring Protocol

WiSys is seeking a strategic partner in the time-sensitive networking industry who can provide a route to market for the commercialization and use of these Precision Delay Monitoring protocols.

Quorum Quenching Functional Enzymes to Inhibit Bacterial Soft Rot

WiSys is seeking strategic partners interested in the commercial use of this innovation.

Immunogenic Composition to Prevent Francisella Infections in Fish

Researchers from the University of Wisconsin - Stevens Point are part of a multi-institution research team that has developed a vaccine with proven efficacy in preventing Francisella infections in fish.

Engineered Bacterial Strain And Method of Use For One-Pot Vitamin C Synthesis

WiSys is seeking strategic partners interested in the commercial use of this innovation

Retrofit Peltier Cooling Device

WiSys is seeking a strategic partner skilled in the manufacturing and distribution of insulated storage containers or portable mini refrigerators.  Ideally, this partner could provide a route to market for the commercialization and use of this retrofit Peltier cooling device.

Optimized Method for the Aqueous Extraction of Anthocyanins from Fruit Waste

WiSys is seeking a strategic partner interested in providing a route to market for the commercialization and use of this anthocyanin extraction system.  There is also interest in partnering with a fruit processing company for the continued testing and scaling of this system.

Skin Whitening Agent(s)

WiSys Technology Foundation is currently seeking a strategic industry partner to assist in the further development of its lead compound, A11, and related analogues providing a route to market for their use as novel skin whitening/lightening agents.The competitive advantage of these compounds over existing agents on the market is that they produce long-acting and reversible skin lightening with no toxicity.

Interactive Degree Planner

Anti-Anxiety Pharmaceuticals with Reduced Side Effects

Benzodiazepine Derivatives with Reduced Side Effects

The WiSys Technology Foundation is seeking commercial partners interested in developing anxiolytic and anticonvulsant benzodiazepines that offer little or no side effects.